Table 3. Comparison of prevalence for PCV13 additional serotypes and 6C among different vaccinated groups (PCV 10 vs PCV13).
| Serotype | Fully vaccinated Number (%) PCV10 vs PCV13 | Partially vaccinated Number (%) PCV10 vs PCV13 | All vaccinated Number (%) PCV10 vs PCV13 | OR | OR 95% CI | p-value | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Full | Part | All | Full | Part | All | Full | Part | All | ||||
| 3,6A,19A | 9 (11.5%) vs 3 (4.6%) | 14 (14.4%) vs 2 (6.9%) | 23 (13.1%) vs 5 (5.3%) | 0.37 | 0.44 | 0.37 | 0.09–1.45 | 0.09–2.09 | 0.14–1.02 | 0.15 | 0.3 | 0.05 |
| 6C | 5 (6.4%) vs 5 (7.7%) | 13 (13.4%) vs 1 (3.4%) | 18 (10.3%) vs 6 (6.4%) | 1.22 | 0.23 | 0.59 | 0.33–4.45 | 0.03–1.88 | 0.23–1.56 | 0.76 | 0.17 | 0.3 |